The report provides a detailed analysis essential for establishing a Gadodiamide production plant. It encompasses all critical aspects necessary for Gadodiamide production, including the cost of Gadodiamide production, Gadodiamide plant cost, Gadodiamide production costs, and the overall Gadodiamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Gadodiamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Gadodiamide is a contrast agent primarily used in the medical field for enhancing the clarity of magnetic resonance imaging (MRI) scans. It helps improve the visibility of internal organs, blood vessels, and tissues, which makes it easier to detect abnormalities, such as tumours, inflammation, or vascular issues. It also serves as an important contrast agent used in brain and spine scans, where detailed imaging is essential for diagnosis. It is also applied in research settings to study blood-flow patterns, tissue structure, and disease progression with greater accuracy.
The demand for Gadodiamide is mainly driven by its use as an important tool in diagnostic imaging, which largely fuels its market expansion. Its application as a contrast agent in magnetic resonance imaging, where it enhances the clarity of scans, further supports its demand in the medical and pharmaceutical industries. Its application in neurological and spinal imaging, where high-detail visualisation is crucial, further drives its demand in the medical and diagnostic sectors.
Its demand in the diagnostic sector as a contrast agent to support the diagnosis of neurological, vascular, and soft-tissue disorders also strengthens its market expansion. Its role in clinical research, focused on developing safer and more effective contrast agents, also contributes to its market growth. The need for reliable and high-quality contrast media in advanced imaging procedures further promotes its demand in the healthcare and pharmaceutical sectors. Industrial Gadodiamide procurement depends on factors such as the cost and availability of gadolinium raw materials, compliance with strict regulatory and safety standards, and adherence to environmental handling guidelines. Improvements in production technology, consistent supplier performance, sustainability measures, and efficient global distribution also influence procurement strategies and shape the overall market for Gadodiamide.
Raw Material for Gadodiamide Production
According to the Gadodiamide production plant project report, the major raw materials for Gadodiamide production include Bis(2-aminoethyl)-ether Trityl Resin, Nα,Nε-di-Fmoc-L-lysine, Fmoc-Lys(Fmoc)-OH, Piperidine, and Acetic Anhydride.
Production Process of Gadodiamide
The extensive Gadodiamide production cost report consists of the following industrial production process:
-
Production via Chemical Synthesis: The production process of Gadodiamide begins with solid-phase peptide synthesis using bis(2-aminoethyl)-ether trityl resin and Fmoc protection strategy. The process starts by coupling Nα,Nε-di-Fmoc-L-lysine to the resin, followed by acetylation of any unreacted amine groups using acetic anhydride in DMF. After deprotecting the Fmoc group with piperidine in DMF, two additional Fmoc-protected lysine residues are further added using PyBOP and DIPEA as coupling agents. This builds a trilysine core with four reactive amine sites, which are then used to attach the AAZTA(tBu)4C4COOH ligand. Coupling with AAZTA is optimised using PyBOP due to its sensitivity to activation conditions. The final product is cleaved from the resin and purified by HPLC, which results in the formation of high-purity Gadodiamide as the desired product.
Gadodiamide is a gadolinium-based contrast agent that appears as a white to off-white solid powder with no notable odour and is only slightly soluble in water and methanol at room temperature. The molecular formula of the compound is C16H26GdN5O8, and its molar mass is about 573.66 g/mol. The compound has a decomposition-related melting point above 300 degree Celsius, and a loosely referenced bulk density near 1.13 g per cm3 in solution form. It is used intravenously in magnetic resonance imaging to enhance the contrast of blood vessels and tissues. It is recommended to wear appropriate protective clothing and follow safety precautions when handling the pure substance, because gadolinium complexes can pose health risks if mishandled or improperly administered.
